<DOC>
	<DOCNO>NCT01472471</DOCNO>
	<brief_summary>Oxidative stress see child asthma , hard measure . The investigator explore utility use commercially available assay measure oxidative stress urine asthmatic . Additionally , investigator attempt prove oxidative stress high child acute asthma compare stable asthma stress also high child severe clinical asthma exacerbation compare less severe one .</brief_summary>
	<brief_title>Urinary 8-isoprostane Elevated Acute Childhood Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>8-epi-prostaglandin F2alpha</mesh_term>
	<criteria>Group 1 1 . Patients age 418 year 2 . Known stable asthmatic medication medication change 3 week prior enrollment 3 . No asthma hospitalization past 3 month 4 . Parent available consent Group 2 1 . Patients age 418 2 . Known asthmatic , admitted Stony Brook University Hospital status asthmaticus 3 . Parent available consent 1 . Any child document fever within 24 hour study entry 2 . Any child know current history tracheo bronchomalacia 3 . Any child know clinical laboratory evidence shock ( see ) 4 . Any child history documented immunodeficiency , rheumatologic disease , cystic fibrosis , renal dysfunction ( see ) 5 . Any child current recent ( less 1 year ) history tracheostomy 6 . Any child know genetic abnormality 7 . Any pregnant child 8 . Any child history autism 9 . Any child whose parent/caregiver unable give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Childhood Asthma</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Urinary 8-isoprostane</keyword>
</DOC>